OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EBV BILF1 Evolved To Downregulate Cell Surface Display of a Wide Range of HLA Class I Molecules through Their Cytoplasmic Tail
Bryan D. Griffin, Anna M. Gram, Arend Mulder, et al.
The Journal of Immunology (2013) Vol. 190, Iss. 4, pp. 1672-1684
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Etiological factors of nasopharyngeal carcinoma
Sai Wah Tsao, Yim Ling Yip, Chi Man Tsang, et al.
Oral Oncology (2014) Vol. 50, Iss. 5, pp. 330-338
Closed Access | Times Cited: 274

Epstein-Barr virus: Biology and clinical disease
Blossom Damania, Shannon C. Kenney, Nancy Raab‐Traub
Cell (2022) Vol. 185, Iss. 20, pp. 3652-3670
Open Access | Times Cited: 231

Infectious mononucleosis
Henry H. Balfour, Samantha K. Dunmire, Kristin A. Hogquist
Clinical & Translational Immunology (2015) Vol. 4, Iss. 2
Open Access | Times Cited: 209

Epstein-Barr virus: the mastermind of immune chaos
Jean de Melo Silva, Carlos Eduardo de Castro Alves, Gemilson Soares Pontes
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 18

Infectious Mononucleosis
Samantha K. Dunmire, Kristin A. Hogquist, Henry H. Balfour
Current topics in microbiology and immunology (2015), pp. 211-240
Closed Access | Times Cited: 149

Immune Evasion by Epstein-Barr Virus
Maaike E. Ressing, Michiel van Gent, Anna M. Gram, et al.
Current topics in microbiology and immunology (2015), pp. 355-381
Closed Access | Times Cited: 132

Cellular immune controls over Epstein–Barr virus infection: new lessons from the clinic and the laboratory
Alan B. Rickinson, Heather M. Long, Umaimainthan Palendira, et al.
Trends in Immunology (2014) Vol. 35, Iss. 4, pp. 159-169
Open Access | Times Cited: 129

The evolution of natural killer cell receptors
Paola Carrillo-Bustamante, Can Keşmir, Rob J. de Boer
Immunogenetics (2015) Vol. 68, Iss. 1, pp. 3-18
Open Access | Times Cited: 91

Intracellular trafficking of HLA-E and its regulation
Wanlin He, Ester Gea‐Mallorquí, Huw Colin‐York, et al.
The Journal of Experimental Medicine (2023) Vol. 220, Iss. 8
Open Access | Times Cited: 26

An Epstein-Barr virus protein interaction map reveals NLRP3 inflammasome evasion via MAVS UFMylation
Stephanie Pei Tung Yiu, Cassie Zerbe, David Vanderwall, et al.
Molecular Cell (2023) Vol. 83, Iss. 13, pp. 2367-2386.e15
Open Access | Times Cited: 26

Herpesvirus-encoded GPCRs: neglected players in inflammatory and proliferative diseases?
Henry F. Vischer, Marco Siderius, Rob Leurs, et al.
Nature Reviews Drug Discovery (2014) Vol. 13, Iss. 2, pp. 123-139
Closed Access | Times Cited: 84

The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder
Olivia M. Martinez, Sheri M. Krams
Transplantation (2017) Vol. 101, Iss. 9, pp. 2009-2016
Open Access | Times Cited: 81

Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Ubiquitin E3 Ligases Have Stage-Specific Immune Evasion Roles during Lytic Replication
Kevin Brulois, Zsolt Tóth, Lai-Yee Wong, et al.
Journal of Virology (2014) Vol. 88, Iss. 16, pp. 9335-9349
Open Access | Times Cited: 80

Viral manipulation of the host immune response
Allison F. Christiaansen, Steven M. Varga, Juliet V. Spencer
Current Opinion in Immunology (2015) Vol. 36, pp. 54-60
Open Access | Times Cited: 73

Recent advances in viral evasion of the MHC Class I processing pathway
A.B.C. Schuren, Ana I. Costa, Emmanuel J. H. J. Wiertz
Current Opinion in Immunology (2016) Vol. 40, pp. 43-50
Closed Access | Times Cited: 71

Genomic assays for Epstein–Barr virus-positive gastric adenocarcinoma
Margaret L. Gulley
Experimental & Molecular Medicine (2015) Vol. 47, Iss. 1, pp. e134-e134
Open Access | Times Cited: 64

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies
Marcus Bauer, Simon Jasinski‐Bergner, Ofer Mandelboim, et al.
Cancers (2021) Vol. 13, Iss. 20, pp. 5189-5189
Open Access | Times Cited: 53

MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control In Vivo
Anita Murer, Julia Rühl, Andrea Zbinden, et al.
mBio (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 52

Modulation of cellular signaling by herpesvirus-encoded G protein-coupled receptors
Sabrina M. de Munnik, Martine J. Smit, Rob Leurs, et al.
Frontiers in Pharmacology (2015) Vol. 6
Open Access | Times Cited: 51

The unconventional role of HLA-E: The road less traveled
Emma J. Grant, Andrea Nguyen, Christian A. Lobos, et al.
Molecular Immunology (2020) Vol. 120, pp. 101-112
Closed Access | Times Cited: 44

Cutting‐Edge Therapy and Immune Escape Mechanisms in EBV‐Associated Tumors
Jie Wang, Rong Wang, Meifeng Wang, et al.
Medicinal Research Reviews (2025)
Closed Access

Cooperation between Epstein-Barr Virus Immune Evasion Proteins Spreads Protection from CD8+ T Cell Recognition across All Three Phases of the Lytic Cycle
Laura L. Quinn, Jianmin Zuo, Rachel J.M. Abbott, et al.
PLoS Pathogens (2014) Vol. 10, Iss. 8, pp. e1004322-e1004322
Open Access | Times Cited: 51

EBV glycoproteins: where are we now?
Lindsey Hutt‐Fletcher
Future Virology (2015) Vol. 10, Iss. 10, pp. 1155-1162
Open Access | Times Cited: 46

Early T Cell Recognition of B Cells following Epstein-Barr Virus Infection: Identifying Potential Targets for Prophylactic Vaccination
Jill Brooks, Heather M. Long, Rose J. Tierney, et al.
PLoS Pathogens (2016) Vol. 12, Iss. 4, pp. e1005549-e1005549
Open Access | Times Cited: 41

Page 1 - Next Page

Scroll to top